Tot Biopharm, a private equity-backed Chinese cancer drug developer, has filed for a Hong Kong IPO under rules that allow for listings by pre-revenue biotech companies.
Founded in 2009, Tot has seven biological and five chemical drugs in the pipeline, according to a prospectus. One is currently in phase-three clinical trials and three more are in phase one. The most...
China's Reworld has a technology that lowers barriers to entry in online game design, allowing anyone to become a creator. Joy Capital is backing the company to take user-generated content to another level
Pop Mart International Group, China’s largest fashion toy retailer, has filed for a Hong Kong IPO. Sequoia Capital China, Loyal Valley Capital and Huaxing Growth Fund are its three largest institutional backers.
PLMP Venture Capital (PLMP VC), an investor affiliated with a Singaporean financial technology firm, has launched a local exchange for small and medium-sized enterprises (SMEs) in Cambodia.
Indian venture capital player Iron Pillar Capital Management has brought in US-headquartered real estate investment firm Nitya Capital as a strategic investor.